Sources bibliographiques

1. ADLER A.J., FELDMAN J., FRIEDMAN E.A., BERLYNE G.M. Use of extracorporeal ascites dialysis in combined hepatic and renal failure. Nephron, 1982, 30, n° 1, 31-35.
2. ALLEN L., VOGT E. A mechanism of lymphatic absorption from serous cavities. Am. J. Physiol., 1937, 117, 776-782.
3. AMEND W.J.C. Pathogenesis of hepatorenal syndrome. Transplant. Proc., 1993, 25, n° 2, 1730-1733.
4. ANTHONY P.P., ISHAK K.G., NAYAK N.C., POULSEN H.E., SCHEUER P.S., SOBIN L.H. The morphology of cirrhosis. Recommendations on definition, nomenclature and classification by a working group sponsored by the World Health Organisation. J. Clin. Pathol., 1978, 31, n° 5, 395-414.
5. ARNAUD J.P., ADLOFF M. Physiopathologie du péritoine. Péritonisation. - Drainage. Encycl. Méd. Chir., Paris, Techniques chirurgicales, Appareil digestif, fasc. 40070, 1989, 15 p.
6. ARRIEF A.I., CHIDSEY C.A. Renal function in cirrhosis and the effects of PgA1. Am. J. Med., 1974, 56, n° 5, 695-703.
7. ARROYO V., BOSCH J., MAURI M., VIVER J., MAS A., RIVERA F., RODES J. Renin, aldosterone and renal hæmodynamics in cirrhosis with ascites. Eur. J. Clin. Invest., 1979, 9, n° 1, 69-73.
8. ARROYO V., BOSCH J., RODES J. Should the term "hepato-renal syndrome" be used ? In : Hepato-renal Syndrome. Ed. by E. BARTOLI, L. CHAINDUSSI - Padoue : Piccin Editore, 1979.- p. 35.
9. ARROYO V., GINES P., NAVASA M., RIMOLA A. Renal failure in cirrhosis and liver transplantation. Transplant. Proc., 1993, 25, n° 2, 1734-1739.
10. ARROYO V., PLANAS R., GAYA J., DEULOFEU R., RIMOLA A., PEREZ-AYUSO R., RIVERA F., RODES J. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion. Eur. J. Clin. Invest., 1983, 13, n° 3, 271-278.
11. ARROYO V., RODES J. Physiopathologie, clinique et traitement des syndromes œdémateux ascitiques du cirrhotique. Encycl. Méd. Chir., Paris, Foie-pancréas, fasc. 7034 D40, 1986, 12 p.
12. BAGGENSTOSS A.H. Morphological features: their usefulness in the diagnosis, prognosis, and management of cirrhosis. Clin. Gastroenterol., 1975, 4, n° 2, 227-246.
13. BATSHAW M.L., BRUSILOW S.W. Treatment of hyperammoniemic coma caused by inborn errors of urea synthesis. J. Pediatr., 1980, 97, n ° 6, 893-900.
14. BAUM M., STIRLING G.A., DAWSON J.L. Further study into obstructive jaundice and ischaemic renal damage. Br. Med. J., 1969, 2, n° 5651, 229-231.
15. BENHAMOU J.P. Cirrhoses. In : BENHAMOU J.P., ERLINGER S., Maladies du foie et des voies biliaires. - Paris : Flammarion, 1986. - p. 72-76.
16. BERGER J., YANEVA H., NABARRA B. Glomerular changes in patients with cirrhosis of the liver. Adv. Nephrol., 1978, 7, 3-14.
17. BETTER O.S., SCHRIER R.W. Disturbed volume homeostasis in patients with cirrhosis of the liver. Kidney Int., 1983, 23, n° 2, 303-311.
18. BICHET D. Les anomalies de l'excrétion de l'eau et du sodium par le rein au cours de la cirrhose hépatique décompensée. Gastroenterol. Clin. Biol., 1985, 9, n° 11, 829-837.
19. BICHET D., SZATALOWICZ V., CHAIMOVITZ C., SCHRIER R.W. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann. Intern. Med., 1982, 96, n° 4, 413-417.
20. BIOULAC-SAGE P., LE BAIL B. Anatomie normale, histophysiologie. In : Hépatologie. - Coord. M. BOUREL - Paris : Ellipses, 1991. - p. 9-18.
21. BLOODWORTH J.M.B., SOMMERS S.C. "Cirrhotic glomerulosclerosis" a renal lesion associated with hepatic cirrhosis. Lab. Invest., 1959, 8, n° 5, 962-978.
22. BUHAC I., JARMOLYCH J. Histology of the intestinal peritoneum in patients with cirrhosis of the liver and ascites. Am. J. Dig. Dis., 1978, 23, n° 5, 417-422.
23. CHEVILLOTE G., HUBERT J., GEROLAMI A. Complications générales des cirrhoses. Encycl. Méd. Chir., Paris, Foie-pancréas, fasc. 7034 C10, 1983.
24. CHILD III C.G., TURCOTTE J.G. Surgery and portal hypertension. In : The Liver and Portal Hypertension. Ed. by C.G. CHILD III- Philadelphia: W.B. SAUNDERS, 1964.- p. 50.
25. CHMIELEWSKI C., ZELLERS L., EYER J. Continuous arteriovenous hemofiltration in the patient with hepatorenal syndrome. A case study. Crit. Care Nurs. Clin. North Am., 1990, 2, n° 1, 115-122.
26. CLARK F., O'LEARY J.P. Survival associated with hepatorenal syndrome. South. Med. J., 1979, 72, n° 1, 87-90.
27. CORATELLI P., PASSAVANTI G., MUNNO I., FUMAROLA D., AMERIO A. New trends in hepatorenal syndrome. Kidney Int. Suppl., 1985, 28, n° 17, S143-S147.
28. CUERVAS-MONS V., MILLAN I., GAVALER J.S., STARZL T.E., VAN THIEL D.H. Pronostic value of preoperatively obtained clinical and laboratory data in predicting survival following orthotopic liver transplantation. Hepatology, 1986, 6, n° 5, 922-927.
29. DADONE C., PINCELLA G., BONOLDI G., SFORZINI S., REDAELLI B. Transport of water and solutes in uremic patients with chronic hepatic disease in CAPD. Adv. Perit. Dial., 1990, 6, 23-25.
30. DASKALOPOULOS G., JORDAN D.R., REYNOLDS T.B. Randomised trial of peritoneovenous shunt (PVS) in the treatment of hepatorenal syndrome (HRS). Gastroenterology, 1985, 88, n° 5 part 2, 1655.
31. DAWSON J.L. Jaundice and anorexic renal damage : protective effect of mannitol. Br. Med. J., 1964, 1, n° 5386, 810-811.
32. DENIS J., OPOLON P., NUSINOVICI V., GRANGER A., DARNIS F. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane. Gut, 1978, 19, n° 9, 787-793.
33. Diseases of the liver and biliary tract. Standardization of nomenclature diagnostic criterals and diagnostic methodology. Ed. by Fogarty International Center. - Washington : U.S. Government Printing Office, 1974.- p. 17-24.
34. DOBBIE J.W., ZAKI M., WILSON L. Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott. Med. J., 1981, 26, n° 3, 213-223.
35. DUGENET D., DROUART M., SAUVAGEOT M. Surveillance de l'équilibre glycémique. II - La fructosamine. Concours Méd., 1993, 115, n° 30, 2561-2566.
36. DURAND P-Y., FREIDA P., CHANLIAU J., GAMBERONI J., HESTIN D., KESSLER M. Long-term follow-up in cirrhotic patients with chronic renal failure undergoing CAPD. (Abstracts of the XIII Annual CAPD Conference, San Diego, Californie, 7-9 Mars 1993) Perit. Dial. Int., 1993, 13, Suppl. n° 1, S47.
37. EKNOYAN G. Glomerular abnormalities in liver disease. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 154-181.
38. ELLIS D., AVNER E.D. Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation. Clin. Nephrol., 1986, 25, n° 6, 295-303.
39. EPSTEIN M. Deranged sodium homeostasis in cirrhosis. Gastroenterology, 1979, 76, n° 3, 622-635.
40. EPSTEIN M. Hepatorenal syndrome. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 89-118.
41. EPSTEIN M. Hepatorenal syndrome. In : Bockus Gastroenterology. Ed. by J.E. BERK. 4th Ed. - Philadelphia : W.B. Saunders, 1982.- p. 3138-3149.
42. EPSTEIN M. Renal sodium handling in liver disease. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 3-30.
43. EPSTEIN M. Role of the peritoneovenous shunt in the management of ascites and the hepatorenal syndrome. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 593-612.
44. EPSTEIN M. The LeVeen shunt for ascites and hepatorenal syndrome. N. Engl. J. Med., 1980, 302, n° 11, 628-630.
45. EPSTEIN M. The peritoneovenous shunt in the management of ascites and the hepatorenal syndrome. Gastroenterology, 1982, 82, n°4, 790-799.
46. EPSTEIN M., BERK D.P., HOLLENBERG N.K., ADAMS D.F., CHALMERS T.C., ABRAMS H.L., MERRILL J.P. Renal failure in patients with cirrhosis. The role of active vasoconstriction. Am. J. Med., 1970, 49, n° 2, 175-185.
47. EPSTEIN M., SCHNEIDER N., BEFELER B. Relationship of systemic and intrarenal hemodynamics in cirrhosis. J. Lab. Clin. Med., 1977, 89, n° 6, 1175-1187.
48. FALLER B. La dialyse péritonéale continue ambulatoire. Rev. Prat. (Paris), 1991, 41, n° 12, 1080-1085.
49. FEVERY J., VAN CUTSEM E., NEVENS F., VAN STEENBERGEN W., VERBERCKMOES R., DE GROOTE J. Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration. J. Hepatol., 1990, 11, n° 2, 153-158.
50. FISCHER E.R., PEREZ-STABLE E. Cirrhotic (hepatic) lobular glomerulonephritis. Correlation of ultrastructural and clinical features. Am. J. Pathol., 1968, 52, n° 4, 869-890.
51. FLINT A. Clinical report on hydro-peritoneum, based on an analysis of forty-six cases. Am. J. Med. Sci., 1863, 45, 306-339.
52. FLOREY H.W. Reactions of, and absorption by, lymphatics, with special reference to those of the diaphragm. Br. J. Exp. Pathol., 1927, 8, 479-490.
53. FREEMAN S. Recent progress in the physiology and biochemistry of the liver. Med. Clin. North Am., 1953, 37, 109-126.
54. FREIDA P., ALBAROUDI H., PERRIER C., POTIER J. La dialyse péritonéale dans le traitement de l'insuffisance rénale chez le cirrhotique. (Résumés des communications du Premier Symposium du Registre de Dialyse Péritonéale de Langue Française) Bulletin de Dialyse Péritonéale, 1991, 1, n° 3, 48.
55. FULLEN W.D. Hepatorenal syndrome: reversal by peritoneovenous shunt. Surgery, 1977, 82, n° 3, 337-341.
56. GENTILINI P., LAFFI G. Pathophysiology and treatment of ascites and the hepatorenal syndrome. Baillieres Clin. Gastroenterol., 1992, 6, n° 3, 581-607.
57. GIBSON J.B., SMITH J.C. The origin of ascites in experimental cirrhosis in the rat. Am. J. Pathol., 1962, 41, 535-547.
58. GINES A., SALMERON J.M., GINES P., ARROYO V., JIMENEZ W., RIVERA F., RODES J. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure. J. Hepatol., 1993, 17, n° 2, 220-226.
59. GINES P., ARROYO V., RODES J. Treatment of ascites and renal failure in cirrhosis. Baillieres Clin. Gastroenterol., 1989, 3, n° 1, 165-186.
60. GINES P., ARROYO V., VARGAS V., PLANAS R., CASAFONT F., PANES J. et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N. Engl. J. Med., 1991, 325, n° 12, 829-835.
61. GLUCK Z., NOLPH K.D. Ascites associated with end-stage renal disease. Am. J. Kidney Dis., 1987, 10, n° 1, 9-18.
62. GOKAL R., FRANCIS D., GOODSHIP T., BINT A.J., RAMOS J.M., FERNER R.E. et al. Peritonitis in continuous peritoneal dialysis. Laboratory and clinical studies. Lancet, 1982, 2, n° 8312, 1388-1391.
63. GONWA T.A., MORRIS C., GOLDSTEIN R.M., HUSBERG B.S., KLINTMALM G.B. Long-term survival and renal function following liver transplantation in patients with or without hepatorenal syndrome - experience in 300 patients. Transplantation, 1991, 51, n° 2, 428-430.
64. GONWA T.A., POPLAWSKI S., PAULSEN W., BRAJTBORD D., GOLDSTEIN R., HUSBERG B., KLINTMALM G.B. Pathogenesis and outcome of hepatorenal syndrome in patients undergoing orthotopic liver transplant. Transplantation, 1989, 47, n° 2, 395-397.
65. GOTLOIB L. Anatomy of the peritoneal membrane. In : Peritoneal dialysis. - Ed. by G. LA GRECA, G. BIASOLI, C. RONCO - Milan: Wichtig, 1982.- p. 17-30.
66. GOTLOIB L., SHUSTACK A. Ultrastrucural morphology of the peritoneum : new findings and speculations on transfer of solutes and water during peritoneal dialysis. Perit. Dial. Bull., 1987, 7, n° 3, 119-129.
67. GRANGER H.J., LAINE G.A. Consecutive barriers to mouvement of water and solutes across the livers sinusoids. Physiologist, 1980, 23, n° 1, 83-85.
68. GUYTON A.C. The lymphatic system, interstitial fluid dynamics, edema, and pulmonary fluid. In : GUYTON A.C.- Textbook of Medical Physiology. 6th Edition. - Philadelphia: Saunders, 1981.- p. 370-382.
69. HALSTEAD A.C., NANJI A.A. Artefactual lowering of serum creatinine in the presence of hyperbilirubinemia - a method dependent artifact. JAMA, 1984, 251, n° 1, 38-39.
70. HARIPRASAD M.K., PAUL P.K., EISENGER R.B., GARY N.E., TIMINS J.E., MILLER J.W. Extracorporeal dialysis of ascites. A new technique. Arch. Intern. Med., 1981, 141, n° 11, 1550-1551.
71. HYATT R.E., SMITH J.R. The mechanism of ascites: a physiologic appraisal. Am. J. Med., 1954, 16, 434-448.
72. INFANTE-RIVARD C., ESNAOLA S., VILLENEUVE J.P. Clinical and statistical validity of conventionnal pronostic factors in predicting short-term survival among cirrhotics. Hepatology, 1987, 7, n° 4, 660-664.
73. INGS T.S., DAUGIRDAS J.T., POPLI S., KHEIRBEK A.O., HUMAYUN H.M., GANDHI V.C., CHAPA S.M. Treatment of refractory hemodialysis ascites with maintenance peritoneal dialysis. Clin. Nephrol., 1981, 15, n° 4, 198-202.
74. ITWASUKI S., POPOVTZER M.M., CORMAN J.L., ISHIKAWA M., PUTNAM C.W., KATZ F.H., STARZL T.E. Recovery from hepatorenal syndrome after orthotopic liver transplantation. N. Engl. J. Med., 1973, 289, n° 22, 1155-1159.
75. JACOBSON S., BELL B. Recognition and management of acute and chronic hepatic encephalopathy. Med. Clin. North Am.,1973, 57, n° 6, 1569-1577.
76. KAGAN A., BAR-KHAYIM Y., SCHAFER Z., FAINARU M. Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins. Kidney Int., 1990, 37, n° 3, 971-979.
77. KEARNS P.J., POLHEMUS R.J., OAKES D., RABKIN R. Hepatorenal syndrome managed with hemodialysis then reversed by peritoneovenous shunting. J. Clin. Gastroenterol., 1985, 7, n° 4, 341-343.
78. KELLER F., WAGNER K., LENZ T., POMMER W., HAHN G., MOLZAHN M., KRAUSE P.H. Hæmodialysis in 'hepatorenal syndrome': report on two cases. Gut, 1985, 26, n° 2, 208-211.
79. KEW M.C., VARMA R.R., WILLIAMS H.S., BRUNT P.W., HOURIGAN K.J., SHERLOCK S. Renal and intrarenal blood flow in cirrhosis of the liver. Lancet, 1971, 2, n° 7723, 504-510.
80. KHANNA R., NOLPH K.D. The physiology of peritoneal dialysis. Am. J. Nephrol., 1989, 9, n ° 6, 504-512.
81. KHANNA R., NOLPH K.D., OREOPOULOS D.G. et al. The Essentials of Peritoneal Dialysis. - Dordrecht : Kluwer Academic Publishers, 1992.- p. 1-53, p. 89-98.
82. KOPPEL M.H., COBURN J.W., MIMS M.M., GOLDSTEIN H., BOYLE J.D., RUBINI M.E. Transplantation of cadaveric kidneys from patients with hepatorenal syndrome: evidence for the functional nature of renal failure in advanced liver disease. N. Engl. J. Med., 1969, 280, n° 25, 1367-1371.
83. KREBS R., FLYNN M. Treatment of hepatic coma with exchange transfusion and peritoneal dialysis. JAMA, 1967, 199, n° 6, 430-432.
84. LAKE J.R., RING E., LABERGE J., GORDON R., ROBERTS J., ASCHER N. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiensy. Transplant. Proc., 1993, 25, n° 2, 1766-1767.
85. LANDINI S., COLI U., LUCATELLO S., FRACASSO A., MORACHIELLO P., TOFFOLETTO P., BAZZATO G. Plasma-exchange e dialisi. Trattamanto combinato nelle insufficienze renali acute secondarie a gravi epatopatie. (Plasmaexchange and dialysis. Combined treatment in acute renal insufficiency secondary to severe hepatopathies.) Minerva Nefrol., 1981, 28, n° 2, 179-186. (article en italien; résumé en anglais)
86. LE VEEN H.H., CHRISTOUDIAS G., IP M., LUFT R., FALK G., GROSBERG S. Peritoneo-venous shunting for ascites. Ann. Surg., 1974, 180, n° 4, 580-591.
87. LEVY M. Hepatorenal syndrome [clinical conference]. Kidney Int., 1993, 43, n° 3, 737-753.
88. LEVY M. Pathophysiology of ascites formation. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 209-243.
89. LEVY M., WEXLER M.J. Renal sodium retention and ascites formation in dogs with experimental cirrhosis but without portal hypertension or increased splanchnic vascular capacity. J. Lab. Clin. Med., 1978, 91, 520-536.
90. LIEBERMAN F.L., DENISON E.K., REYNOLDS T.B. The relationship of plasma volume, portal hypertension, ascites and renal retention in cirrhosis: the overflow theory of ascites formation. Ann. N. Y. Acad. Sci., 1970, 170, 202-206.
91. LIEBERMAN F.L., ITO S., REYNOLDS T.B. Effective plasma volume in cirrhosis with ascites. Evidence that a decreased volume does not account for renal sodium retention, a spontaneous reduction in glomerular filtration rate (GFR), and a fall in GFR during drug-induced diuresis. J. Clin. Invest., 1969, 48, n° 6, 975-981.
92. LIEBERMAN F.L., REYNOLDS T.B. Plasma volume in cirrhosis of the liver: its relation to portal hypertension, ascites and renal failure. J. Clin. Invest., 1967, 46, n° 8, 1297-1308.
93. LINAS S.L., SCHAEFER J.W., MOORE E.E., GOOD J.T. Jr, GIANSIRACUSA R. Peritoneovenous shunt in the management of the hepatorenal syndrome. Kidney Int., 1986, 30, n° 5, 736-740.
94. MACTIER R.A. Non-renal indications for peritoneal dialysis. Adv. Perit. Dial., 1992, 8, 141-144.
95. MACTIER R.A. Role of lymphatics in peritoneal dialysis. Ren. Fail., 1990, 12, n° 1, 21-24.
96. MACTIER R.A., DOBBIE J.W., KHANNA R. Peritoneal dialysis in fulminant hepatic failure. Perit. Dial. Bull., 1986, 6, n° 4, 199-202.
97. MACTIER R.A., KHANNA R. Peritoneal cavity lymphatics. In : Peritoneal Dialysis. Ed. by K.D. NOLPH. 3rd Ed. - Dordrecht : Kluwer Academic Publishers, 1989.- p. 48-66.
98. MACTIER R.A., KHANNA R., TWARDOWSKI Z.J., MOORE H., NOLPH K.D. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in CAPD. J. Clin. Invest., 1987, 80, n° 5, 1311-1316.
99. MACTIER R.A., KHANNA R., TWARDOWSKI Z.J., NOLPH K.D. Failure of ultrafiltration in CAPD due to excessive lymphatic absorption. Am. J. Kidney Dis., 1987, 10, n° 6, 461-466.
100. MALLET-GUY P., DEVIC G., FEROLDI J., DESFACQUES P. Etude expérimentale des ascites: sténoses veineuses post-hépatiques et transposition du foie dans le thorax. Lyon Chir., 1954, 49, 153-165.
101. MARCUS R.G., MESANA J., SWARTZ R. Peritoneal dialysis in end-stage renal disease patients with preexisting chronic liver disease and ascites. Am. J. Med., 1992, 93, n° 1, 35-40.
102. MARKOWITZ J.J., ARCHIBALD J., DOWNIE H.G. Experimental Surgery. 5th Ed.- Baltimore : Williams and Wilkins, 1964.- p. 425-427.
103. MARTIN E. Anatomie pathologique des cirrhoses et des lésions pré-cirrhotiques. Encycl. Méd. Chir., Paris, Foie-pancréas, fasc. 7034 A10, 5-1983.
104. MIGUET J.-P., BRESSON-HADNI S., JOBARD J.-M., BECKER M.-C. Physiopathologie et traitement de l'ascite des cirrhoses. Rev. Prat. (Paris), 1986, 36, n° 39, 2267-2275.
105. MORRIS B. The hepatic and intestinal contributions to the thoracic duct lymph. Q.J. Exp. Physiol., 1956, 41, 318-325.
106. NANJI A.A., HALSTEAD A.C. Spurious decrease in serum creatinine in patients with hyperbilirubinemia. Dig. Dis. Sci., 1982, 27, n° 11, 1051.
107. NIENHUIS L.I., MULMED E.I., KELLY J.W. Hepatic coma. Treatment emphasizing merit of peritoneal dialysis. Am. J. Surg., 1963, 106, 980-985.
108. NOLPH K.D., TWARDOWSKI Z.J. The peritoneal dialysis system. In : Peritoneal Dialysis. Ed. by K.D. NOLPH. 3rd Ed. - Dordrecht : Kluwer Academic Publishers, 1989.- p. 13-27.
109. NOMOTO Y., SUGA T., NAKAJIMA K., SAKAI H., OSAWA G., OTA K. et al. Acute hydrothorax in continuous ambulatory peritoneal dialysis-a collaborative study of 161 centers. Am. J. Nephrol., 1989, 9, n° 5, 363-367.
110. OLIN T., SALDEEN T. The lymphatic pathways from the peritoneal cavity: a lymphangiographic study in the rat. Cancer Res., 1964, 24, 1700.
111. PAPADAKIS M., ARIEFF A.I. Unreliability of clinical evaluation of renal function in cirrhosis : a prospective study. Am. J. Med., 1987, 82, n° 5, 945-952.
112. PAPPER S. Hepatorenal syndrome. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 2nd Ed. - New-York : Elsevier Biomedical, 1983.- p. 87-106.
113. PARSONS V., WILKINSON S.P., WESTON M.J. Use of dialysis in the treatment of renal failure in liver disease. Postgrad. Med. J.,1975, 51, 515-520.
114. PEREZ G.O., EPSTEIN M., OSTER J.R. Role of dialysis and ultrafiltration in the treatment of the renal complications of liver disease. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 613-624.
115. PLADSON T.R., PARRISH R.M. Hepatorenal syndrome. Recovery after peritoneovenous shunt. Arch. Intern. Med., 1977, 137, n° 9, 1248-1249.
116. POPOVICH R.P., MONCRIEF J.W., NOLPH K.D., GHODS A.J., TWARDOWSKI Z.J., PYLE W.K. Continuous Ambulatory Peritoneal Dialysis. Ann. Intern. Med., 1978, 88, n° 4, 449-456.
117. POPPER H. Pathologic aspects of cirrhosis. A review. Am. J. Pathol., 1977, 87, n° 1, 228-264.
118. POULOS A.M., HOWARD L., EISELE G., RODGERS J.B. Peritoneal dialysis therapy for patients with liver and renal failure with ascites. Am. J. Gastroenterol., 1993, 88, n° 1, 109-112.
119. PRAGA M., COSTA J.R., SHANDAS G.J., MARTINEZ M.A., MIRANDA B., RODICIO J.L. Acute renal failure in cirrhosis associated with macroscopic hematuria of glomerular origin. Arch. Intern. Med., 1987, 147, n° 1, 173-174.
120. PUGH R.N., MURRAY-LYON I.M., DAWSON J.L., PIETRONI M.C., WILLIAMS R. Transection of the œsophagus for bleeding œsophageal varices. Br. J. Surg., 1973, 60, n° 8, 646-649.
121. RAPPAPORT A.M. Physioanatomic considerations. In : Diseases of the Liver. Ed. by L. SCHIFF, E.R. SCHIFF. 6th Ed. - Philadelphia: J.B. Lippincott, 1987 - p. 1-46.
122. RAPPAPORT A.M. The microcirculatory acinar concept of normal and pathological hepatic structure. Beitr. Pathol., 1976, 157, n° 3, 215-243.
123. RAYBUCK H.E., ALLEN L., HARMS W.S. Absorption of serum from the peritoneal cavity. Am. J. Physiol., 1960, 199, n° 6, 1021-1024.
124. REYNOLDS T.B. Portal hypertension. In : Diseases of the Liver. Ed. by L. SCHIFF. 4th Ed. - Philadelphia: J.B. Lippincott, 1975 - p. 330-367.
125. RIMOLA A., GAVALER J.S., SCHADE R.R., EL-LANKANY S., STARZL T.E., VAN THIEL D.H. Effects of renal impairment on liver transplantation. Gastroenterology, 1987, 93, n° 1, 148-156.
126. RING-LARSEN H. Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver function. Scand. J. Clin. Lab. Invest., 1977, 37, 635-642.
127. RING-LARSEN H., CLAUSEN E., RANEK L. Peritoneal dialysis in hyponatremia due to liver failure. Scand. J. Gastroenterol., 1973, 8, 33-40.
128. RING-LARSEN H., HENRIKSEN J.H., CHRISTENSEN N.J. Increased sympathetic activity in cirrhosis. N. Engl. J. Med., 1983, 308, n° 17, 1029-1030.
129. RING-LARSEN H., PALAZZO U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut, 1981, 22, n° 7, 585-591
130. RITT D.J., WHELAN G., WERNER D.J., EIGENBRODT E.H., SCHENKER S., COMBES B. Acute hepatic necrosis with stupor or coma, an analysis of thirty-one patients. Medicine (Baltimore), 1969, 48, n° 2, 151-172.
131. RUBIN J., KILEY J., RAY R., MACFARLAND S., BOWER J. Continuous ambulatory peritoneal dialysis. Treatment of dialysis related ascites. Arch. Intern. Med., 1981, 141, n° 8, 1093-1095.
132. RYCKELYNCK J.P., VERGER C., CAM G., FALLER B., PIERRE D. Importance of the flush effect in disconnect systems. Adv. Perit. Dial., 1988, 4, 282-284.
133. SALOMON M., SAGAGUCHI H., CHURG J., DACHS S., GRISHMAN E., MAUTNER W. et al. Renal lesions in hepatic disease : a study based on kidney biopsies. Arch. Intern. Med., 1965, 115, n° 6, 704-709.
134. SCHAFFNER F., POPPER H. Capillarization of hepatic sinusoïds in man. Gastroenterology, 1963, 44, n° 3, 239-242.
135. SCHELLING J.R., LINAS S.L. Hepatorenal syndrome. Semin. Nephrol., 1990, 10, n° 6, 565-570.
136. SCHRIER R.W., ARROYO V., BERNARDI M., EPSTEIN M., HENRIKSEN J.H., RODES J. Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology, 1988, 8, n° 5, 1151-1157.
137. SCHROEDER E.T., NUMANN P.J., CHAMBERLAIN B.E. Functional renal failure in cirrhosis. Recovery after portocaval shunt. Ann. Intern. Med., 1970, 72, n° 6, 923-928.
138. SCHROEDER E.T., SHEAR L., SANCETTA S.M., GABUZDA G.J. Renal failure in patients with cirrhosis of the liver. III. Evaluation of intrarenal blood-flow by para-amino-hippurate extraction and response to angiotensin. Am. J. Med., 1967, 43, n° 6, 887-896.
139. SEGAERT M.F., CARLIER B., VERBANCK J. Recurrent hepatic coma in a chronic hemodialysis patient : successful treatment by CAPD. Perit. Dial. Bull., 1984, 4, n° 1, 32-34.
140. SHEAR L., CHING S., GABUZDA G.J. Compartmentalization of ascites and edema in patients with hepatic cirrhosis. N. Engl. J. Med., 1970, 282, n° 25, 1391-1396.
141. SHEAR L., KLEINERMAN J., GABUZDA G.J. Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am. J. Med., 1965, 39, n° 2, 184-198.
142. SHERLOCK S. Diseases of the Liver and Biliary System. 5th Ed.- Oxford: Blackwell Scientific Publications, 1975.- p. 425-444.
143. SILK D.B.A., WILLIAMS R. Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal hemoperfusion and polyacrylonitrile hæmodialysis. Int. J. Artif. Organs, 1978, 1, n° 1, 29-33.
144. SIMER P.H. The passage of particulate matter from peritoneal cavity into the lymph vessels of the diaphragm. Anat. Rec., 1948, 101, 333-351.
145. SOLEZ K., RACUSEN L.C., JEWELL L.D. Pathology of acute renal failure occuring in liver disease. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.-p. 182-206.
146. STRAND V., MAYOR G., RISTOW G., GREENBAUM D., MAYLE J., ROSENBAUM R. Concomitant renal and hepatic failure treated by polyacrylonitrile membrane hemodialysis. Int. J. Artif. Organs, 1981, 4, n° 3, 136-139.
147. TAYLOR A.E., BAAR K.A., GIBSON H. Effect of tissue pressure on the lymph flow. Biophys. J., 1970, 10, 45A.
148. TENCKHOFF H., WARD G., BOEN S.T. The influence of dialysate volume and flow rate on peritoneal clearance. Proc. Eur. Dial. Transplant Assoc., 1965, 2, 113-117.
149. TOPCHIASHVILI Z.A., SERGIENKO V.S. Gemodialis pri pechenochno-pochechnoj nedostatochnosti. Hirurgija, 1971, 47, 14-16. (TOPSCHIASHVILI Z.A., SERGIENKO V.S. Hemodialysis in hepatorenal insufficiency. Khirurgiia (Mosk), 1971, 47, 14-16) (article en russe; résumé en anglais).
150. TWARDOWSKI Z.J. Clinical values of standardized equilibration tests in CAPD patients. Blood Purif., 1989, 7, n° 2-3, 95-108.
151. TWARDOWSKI Z.J. New approaches to intermittent peritoneal dialysis therapies. In : Peritoneal Dialysis. Ed. by K.D. NOLPH. 3rd Ed. - Dordrecht : Kluwer Academic Publishers, 1989.- p. 133-151.
152. TWARDOWSKI Z.J., NOLPH K.D., KHANNA R., PROWANT B.F., RYAN L.P., MOORE H.L., NIELSEN M.P. Peritoneal equilibration test. Perit. Dial. Bull., 1987, 7, n° 3, 138-147.
153. VAAMONDE C.A. Renal water handling in liver disease. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 31-72.
154. VERGER C. Anatomie et physiologie du péritoine en DPCA : évolution et moyens de surveillance. Nephrologie, 1989, 10, Suppl., 22-29.
155. VERGER C. La dialyse péritonéale chronique. Encycl. Méd. Chir., Paris, Rein, Organes génito-urinaires, fasc. 18062F38, 1987, 10 p.
156. VERGER C., FALLER B., RYCKELYNCK J.-P., GUIBERTEAU R., PIERRE D., BENEVENT D., WONE C. Bilan de cinq années de Dialyse Péritonéale Continue Ambulatoire (DPCA)-(étude multicentrique de 345 patients). Nephrologie, 1985, 6, n° 1, 1-6.
157. VERGER C., LARPENT L., VENIEZ G., BRUNETOT N., CORVAISIER B. L'APEX... description et utilisation. Bulletin de Dialyse Péritonéale, 1991, 1, n° 2, 36-40.
158. VERGER C., LARPENT L., VENIEZ G., CORVAISIER B. Surveillance de la perméabilité du péritoine en dialyse péritonéale. Rev. Prat. (Paris), 1991, 41, n° 12, 1086-1090.
159. VERGER C., LUZAR M.A. In vitro study of CAPD Y-line systems. Adv. Perit. Dial., 1986, 2, 160-164.
160. WAPNICK S., GROSSBERG S., KINNEY M., LEVEEN H.H. LeVeen continuous peritoneal-jugular shunt. Improvement of renal function in ascitic patients. JAMA, 1977, 237, n° 2, 131-133.
161. WILKINSON S.P., MOORE K.P., ARROYO V. Pathogenesis of ascites and hepatorenal syndrome. Gut, 1991 Sep, Suppl., S12-S17.
162. WILKINSON S.P., WESTON M.J., PARSONS V., WILLIAMS R. Dialysis in the treatment of renal failure in patients with liver disease. Clin. Nephrol., 1977, 8, n° 1, 287-292.
163. WITTE C.L., WITTE M.H., DUMONT A.E. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology, 1971, 61, n° 5, 742-750.
164. WITTE C.L., WITTE M.H., DUMONT A.E., FRIST J., COLE W.R. Lymph protein in hepatic cirrhosis and experimental hepatic and portal venous hypertension. Ann. Surg., 1968, 168, 567-577.
165. WITTE M.H. Ascitic, thy lymph runneth over. Gastroenterology, 1979, 76, n° 5, 1066-1068.
166. WITTE M.H., WITTE C.L., DUMONT A.E. Estimated net transcapillary water and protein flux in the liver and intestine of patients with portal hypertension from hepatic cirrhosis. Gastroenterology, 1981, 80, n° 2, 265-272.
167. YORK E.L., GRIEVE S., MIENY C.J. Successful treatment of hepatic coma complicated by renal failure with exchange transfusion and peritoneal dialysis. S. Afr. Med. J., 1973, 4, 655-656.
168. ZIPSER R.D., KRONBORG I.J., RECTOR W., REYNOLDS T., DASKALOPOULOS G. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Gastroenterology, 1984, 87, n° 6, 1228-1232.
169. ZIPSER R.D., LIFSCHITZ M.D. Prostaglandins and related compounds. In : The Kidney in Liver Disease. Ed. by M. EPSTEIN. 3rd Ed. - Baltimore : Williams and Wilkins, 1988.- p. 393-416.
170. ZIPSER R.D., RADVAN G.H., KRONBORG I.J., DUKE R., LITTLE T.E. Urinary thromboxane B2 and prostaglandin E2 in the hepatorenal syndrome: Evidence for increased vasoconstrictor and decreased vasodilatator factors. Gastroenterology, 1983, 84, n° 4, 697-703.
171. ZUSMAN R.M., AXELROD L., TOLKOFF-RUBIN N.E. The treatment of the hepatorenal syndrome (HRS) with intrarenal administration of prostaglandin E1. Prostaglandins, 1977, 13, 819-830.


DETROZ B., HONORE P., MONAMI B., DEWANDRE J.M., DEFRAIGNE J.O., PIROTTE J. et al. Le syndrome hépatorénal. Rev. Med. Liege, 1991, 46, n° 4, 188-195.
FABRE M., MARTIN E. Des lésions anatomiques aux symptômes. Place de la biopsie hépatique au cours de l'évolution de la maladie alcoolique. Rev. Prat. (Paris), 1986, 36, n° 39, 2261-2265.
LEBREC D. Hypertension portale: étiologie et physiopathologie. Encycl. Méd. Chir., Paris, Foie-pancréas, fasc. 7034 D10, 1987, 6 p.
RING-LARSEN H. Hepatic nephropathy, related to hæmodynamics. Liver, 1983, 3, n° 5, 265-289.
RONDEAU E., LACAVE R., SRAER J.-D. Le traitement des insuffisances rénales aiguës. Rev. Prat. (Paris), 1987, 37, n° 31, 1863-1870.
STRAUCH M., WALZER P., VON HENNING G.E., ROETTGER G., CHRIST H. Factors influencing protein loss during peritoneal dialysis. Trans. - Am. Soc. Artif. Intern. Organs, 1967, 13, 172-175.81.

Table des matières

“Par délibération de son conseil en date du 10 Novembre 1972, l’Université n’entend donner aucune approbation ni improbation aux opinions émises dans les thèses ou mémoires. Ces opinions doivent être considérées comme propres à leurs auteurs.”




L’association d’une hépatopathie chronique ou aiguë et d’une insuffisance rénale est habituellement grevée d’une mortalité très importante. La dialyse péritonéale était jusqu’à une date récente considérée comme inefficace dans ce tableau. La revue de la littérature sur cette pathologie et son traitement à l’aide de la dialyse péritonéale, ainsi que l’étude de huit patients, permet pourtant d’affirmer que dans ses modalités actuelles la dialyse péritonéale constitue un traitement substitutif de choix en cas d’insuffisance rénale chez un patient souffrant d’une hépatopathie sévère, que ce soit dans le cadre de l’insuffisance rénale aiguë ou dans celui de l’insuffisance rénale chronique.


Dialyse péritonéale
Rénale, Insuffisance
Hépatite aiguë